These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35027560)

  • 1. The breast pre-cancer atlas illustrates the molecular and micro-environmental diversity of ductal carcinoma in situ.
    Nachmanson D; Officer A; Mori H; Gordon J; Evans MF; Steward J; Yao H; O'Keefe T; Hasteh F; Stein GS; Jepsen K; Weaver DL; Hirst GL; Sprague BL; Esserman LJ; Borowsky AD; Stein JL; Harismendy O
    NPJ Breast Cancer; 2022 Jan; 8(1):6. PubMed ID: 35027560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma
    Pareja F; Brown DN; Lee JY; Da Cruz Paula A; Selenica P; Bi R; Geyer FC; Gazzo A; da Silva EM; Vahdatinia M; Stylianou AA; Ferrando L; Wen HY; Hicks JB; Weigelt B; Reis-Filho JS
    Clin Cancer Res; 2020 Jul; 26(14):3682-3693. PubMed ID: 32220886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.
    Done SJ; Arneson NC; Ozçelik H; Redston M; Andrulis IL
    Cancer Res; 1998 Feb; 58(4):785-9. PubMed ID: 9485035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis.
    Murphy DS; Hoare SF; Going JJ; Mallon EE; George WD; Kaye SB; Brown R; Black DM; Keith WN
    J Natl Cancer Inst; 1995 Nov; 87(22):1694-704. PubMed ID: 7473818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.
    Elsarraj HS; Hong Y; Valdez KE; Michaels W; Hook M; Smith WP; Chien J; Herschkowitz JI; Troester MA; Beck M; Inciardi M; Gatewood J; May L; Cusick T; McGinness M; Ricci L; Fan F; Tawfik O; Marks JR; Knapp JR; Yeh HW; Thomas P; Carrasco DR; Fields TA; Godwin AK; Behbod F
    Breast Cancer Res; 2015 Sep; 17():128. PubMed ID: 26384318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtypes of high-grade breast ductal carcinoma in situ (DCIS): incidence and potential clinical impact.
    Schandiz H; Park D; Kaiser YL; Lyngra M; Talleraas IS; Geisler J; Sauer T
    Breast Cancer Res Treat; 2023 Sep; 201(2):329-338. PubMed ID: 37453021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology.
    McCart Reed AE; Kutasovic JR; Nones K; Saunus JM; Da Silva L; Newell F; Kazakoff S; Melville L; Jayanthan J; Vargas AC; Reid LE; Beesley J; Chen XQ; Patch AM; Clouston D; Porter A; Evans E; Pearson JV; Chenevix-Trench G; Cummings MC; Waddell N; Lakhani SR; Simpson PT
    J Pathol; 2018 Apr; 244(4):460-468. PubMed ID: 29344954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers.
    Schultz S; Bartsch H; Sotlar K; Petat-Dutter K; Bonin M; Kahlert S; Harbeck N; Vogel U; Seeger H; Fehm T; Neubauer HJ
    BMC Med Genomics; 2018 Sep; 11(1):80. PubMed ID: 30236106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ductal Carcinoma In Situ - Quo Vadis?
    Peltecu G
    Chirurgia (Bucur); 2021 Dec; 116(5 Suppl):S5-S6. PubMed ID: 34967322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ductal carcinoma in situ of the breast: histological classification and genetic alterations.
    van de Vijver MJ
    Recent Results Cancer Res; 1998; 152():123-34. PubMed ID: 9928552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lobular Carcinomas
    Lee JY; Schizas M; Geyer FC; Selenica P; Piscuoglio S; Sakr RA; Ng CKY; Carniello JVS; Towers R; Giri DD; de Andrade VP; Papanastasiou AD; Viale A; Harris RS; Solit DB; Weigelt B; Reis-Filho JS; King TA
    Clin Cancer Res; 2019 Jan; 25(2):674-686. PubMed ID: 30185420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.
    Fujii H; Szumel R; Marsh C; Zhou W; Gabrielson E
    Cancer Res; 1996 Nov; 56(22):5260-5. PubMed ID: 8912866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer.
    Muggerud AA; Hallett M; Johnsen H; Kleivi K; Zhou W; Tahmasebpoor S; Amini RM; Botling J; Børresen-Dale AL; Sørlie T; Wärnberg F
    Mol Oncol; 2010 Aug; 4(4):357-68. PubMed ID: 20663721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection and evolution in the genomic landscape of copy number alterations in ductal carcinoma in situ (DCIS) and its progression to invasive carcinoma of ductal/no special type: a meta-analysis.
    Rane SU; Mirza H; Grigoriadis A; Pinder SE
    Breast Cancer Res Treat; 2015 Aug; 153(1):101-21. PubMed ID: 26255059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational profiling of micro-dissected pre-malignant lesions from archived specimens.
    Nachmanson D; Steward J; Yao H; Officer A; Jeong E; O'Keefe TJ; Hasteh F; Jepsen K; Hirst GL; Esserman LJ; Borowsky AD; Harismendy O
    BMC Med Genomics; 2020 Nov; 13(1):173. PubMed ID: 33208147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep-learning model to improve histological grading and predict upstaging of atypical ductal hyperplasia / ductal carcinoma in situ on breast biopsy.
    Huang CY; Chang RF; Lin CY; Hsieh MS; Liao PC; Wang YJ; Kao YC; Porta L; Lin PY; Lee CC; Lee YH
    Histopathology; 2024 May; 84(6):983-1002. PubMed ID: 38288642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Escape in Breast Cancer During
    Gil Del Alcazar CR; Huh SJ; Ekram MB; Trinh A; Liu LL; Beca F; Zi X; Kwak M; Bergholtz H; Su Y; Ding L; Russnes HG; Richardson AL; Babski K; Min Hui Kim E; McDonnell CH; Wagner J; Rowberry R; Freeman GJ; Dillon D; Sorlie T; Coussens LM; Garber JE; Fan R; Bobolis K; Allred DC; Jeong J; Park SY; Michor F; Polyak K
    Cancer Discov; 2017 Oct; 7(10):1098-1115. PubMed ID: 28652380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes.
    Goh CW; Wu J; Ding S; Lin C; Chen X; Huang O; Chen W; Li Y; Shen K; Zhu L
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1877-1886. PubMed ID: 31089799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer.
    Johnson KC; Koestler DC; Fleischer T; Chen P; Jenson EG; Marotti JD; Onega T; Kristensen VN; Christensen BC
    Clin Epigenetics; 2015; 7(1):75. PubMed ID: 26213588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic clonal mapping of in situ and invasive ductal carcinoma indicates the field cancerization phenomenon in the breast.
    Foschini MP; Morandi L; Leonardi E; Flamminio F; Ishikawa Y; Masetti R; Eusebi V
    Hum Pathol; 2013 Jul; 44(7):1310-9. PubMed ID: 23337025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.